Zamansky LLC Investigates C.R. Bard Inc. On Behalf Of Long-Term Shareholders Over Allegations Related to Vaginal-Mesh Implants

Share Article

Zamansky LLC investigates C.R. Bard Inc. on behalf of long-term shareholders over allegations related to its Avaulta vaginal-mesh implants. The investigation concerns whether C.R. Bard's officers or directors had knowledge of the potential danger of its product to patients, and breached fiduciary duties to shareholders.

Zamansky LLC announces that it has commenced an investigation of C.R. Bard Inc. ("CR Bard"), the Murray Hill, New Jersey-based medical and surgical device company on behalf of its long-term shareholders. The investigation concerns whether CR Bard's officers and directors allegedly breached fiduciary duties to shareholders, in light of reports that its officers and directors know of the potential dangers of its vaginal-mesh implants to patients.

On August 15, 2013, BusinessWeek reported that CR Bard lost the first federal trial by a patient other alleged defects in its Avaulta vaginal-mesh implants. The case was Donna Cisson v. C. R. Bard, U.S. District Court, N.D. Georgia, Atlanta Division, 11-CV-195. The verdict was for $250,000 in compensatory damages and $1.75 million in punitive damages, BusinessWeek reports, and that CR Bard faces another 8,000 lawsuits.

Before the trial, on July 26, 2013, BloombergNews reported that documents unsealed by the Court in the lawsuit included internal emails that executives at CR Bard's Davon unit knew that the manufacturer of the resin material used in the mesh implants had warned that it not be used in humans, and warned not to reveal to the resin manufacturer that the material would be used for implants.

Zamansky LLC is investigating potential breaches of fiduciary duty by CR Bard towards its long-term shareholders, in view of the allegations in the lawsuit and its results. According to stock fraud attorney Jake Zamansky, long-term shareholders have a right to be concerned about whether CR Bard's officers and directors had knowledge of the potential dangers of its product, and the resulting litigation and other costs to the company from proceeding forward despite the danger.

What Long-Term Shareholders Can Do

If you are a CR Bard investor who invested and held the stock many years, and who still holds the stock, you may, without obligation or cost to you, email jake(at)zamansky(dot)com or call the law firm at (212) 742-1414 to discuss your legal rights.

To learn more about Zamansky LLC, please visit our website,

About Zamansky LLC

Zamansky LLC is one of the leading securities fraud law firms specializing in securities class actions and securities arbitration, and investment fraud litigation. We are stock fraud attorneys who represent both individual and institutional investors. Our practice is nationally recognized for our ability to aggressively prosecute cases and recover losses.


Zamansky LLC
50 Broadway - 32nd Floor
New York, NY 10004
Jake Zamansky, 212-742-1414

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jacob Zamansky
Zamansky & Associates LLC
212 742-1414
Email >
Visit website